| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6095743 | Gastroenterology | 2011 | 12 Pages |
Abstract
IL-35 controls the development of T-cell-dependent colitis in mice. It might be developed as a therapeutic target for patients with chronic intestinal inflammation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Stefan Wirtz, Ulrike Billmeier, Tamuna Mchedlidze, Richard S. Blumberg, Markus F. Neurath,